Myocardial Infarction — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for myocardial infarction. 18 active patents protecting 2 drugs from 2+ originators. First major cliff: 2029. Daily refresh.

2
Approved drugs
18
Active US patents
50/100
Avg vulnerability
—
Annual revenue covered

Originators in Myocardial Infarction

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Merck/AstraZeneca) 12 patents Idorsia 6 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating myocardial infarction. Each bar = one year. Y-axis scaled to peak year (12 patents).

1
29
12
35
1
37
4
38

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Zestril
lisinopril
 Generic (originally Merck/AstraZeneca) 12 36 — 2035-11-06
Tryvio
APROCITENTAN
 Idorsia 6 63 — 2029-09-21

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8324232 Tryvio method of use 81 2029-09-21
11174247 Tryvio method of use 75 2037-11-06
11787782 Tryvio method of use 75 2038-03-02
11680058 Tryvio method of use 75 2038-07-26
12433931 Zestril method of use 58 2035-11-06
12297189 Tryvio formulation 55 2038-02-26
10406199 Zestril method of use 45 2035-11-06
10039800 Zestril method of use 45 2035-11-06
9616096 Zestril method of use 45 2035-11-06
12186360 Zestril formulation 38 2035-11-06

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10919881 Tryvio composition of matter 17 2038-02-26
10265370 Zestril formulation 25 2035-11-06
9463183 Zestril formulation 25 2035-11-06
9814751 Zestril formulation 25 2035-11-06
11179434 Zestril formulation 25 2035-11-06
10940177 Zestril formulation 25 2035-11-06
11771733 Zestril formulation 33 2035-11-06
12186360 Zestril formulation 38 2035-11-06
12128083 Zestril formulation 38 2035-11-06
10406199 Zestril method of use 45 2035-11-06

Related